← FDA DRUG APPROVALS

FDA ANDA · ANDA040009

ISOSORBIDE DINITRATE

Sponsor: SUN PHARM INDS INC

APPLICATION
ANDA040009
TYPE
ANDA
ORIGINAL APPROVAL
1998-12-30
LATEST ACTION
2014-11-19
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

ISOSORBIDE DINITRATEDiscontinued
ISOSORBIDE DINITRATE 40MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2014-11-19Manufacturing (CMC) · Supplement 8 · unknownAP
2002-05-07Labeling · Supplement 2AP
2001-04-23Manufacturing (CMC) · Supplement 1AP
1998-12-30OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →